India's Pharmaceutical Exports

Country Profile

Saudi Arabia

Saudi Arabia is a significant market for Indian pharmaceutical exports — $186M in FY 2025–26, with 4.2× growth over the past decade. Medicines accounts for 67% of shipments, with vaccines contributing $2.79M. The compound annual growth rate since FY2015 stands at 13.9%.

🇸🇦 $186M · 4.2× growth since FY2015 · 13.9% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$186M
Exports FY2025–26 DGCIS
4.2×
Growth FY2015→2026
13.9%
CAGR FY2015→2026
67%
Medicines Share
5
Product Categories Supplied
Saudi Arabia is a significant market for Indian pharmaceutical exports — $186M in FY 2025–26, with 4.2× growth over the past decade. Medicines accounts for 67% of shipments, with vaccines contributing $2.79M. The compound annual growth rate since FY2015 stands at 13.9%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $125M (67.2%) Medicine Ingredients $43.4M (23.3%) Surgical & Hospital Supplies $10.4M (5.6%) Traditional & Herbal $4.52M (2.4%) Vaccines $2.79M (1.5%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Saudi Arabia in the RBI overseas direct investment dataset (2011–2026).